We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+35.35%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$12.8B
AUM Growth
+$3.79B
Cap. Flow
+$2.28B
Cap. Flow %
17.8%
Top 10 Hldgs %
15.6%
Holding
2,120
New
741
Increased
362
Reduced
312
Closed
513

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 3.1%
2 Technology 2.68%
3 Healthcare 2.33%
4 Communication Services 1.06%
5 Financials 0.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRN icon
1251
Trinity Industries
TRN
$3.03B
$618K ﹤0.01%
+22,050
New +$608K
ADT icon
1252
CALL
ADT
ADT
$5.35B
$613K ﹤0.01%
70,400
TENB icon
1253
Tenable Holdings
TENB
$3.5B
$612K ﹤0.01%
+21,000
New +$656K
FLYW icon
1254
CALL
Flywire
FLYW
$2.02B
$609K ﹤0.01%
45,000
ERO icon
1255
Ero Copper
ERO
$2.69B
$606K ﹤0.01%
+29,964
New +$456K
SPRY icon
1256
CALL
ARS Pharmaceuticals
SPRY
$569M
$603K ﹤0.01%
60,000
-40,500
-40% -$581K
NAK
1257
CALL
Northern Dynasty Minerals
NAK
$818M
$600K ﹤0.01%
+500,000
New +$537K
PRTA icon
1258
Prothena Corp
PRTA
$442M
$595K ﹤0.01%
61,009
-4,091
-6% -$31.4K
ORIC icon
1259
Oric Pharmaceuticals
ORIC
$1.24B
$593K ﹤0.01%
+49,389
New +$520K
AEO icon
1260
American Eagle Outfitters
AEO
$3.03B
$590K ﹤0.01%
+34,500
New +$472K
FHN icon
1261
CALL
First Horizon
FHN
$12.3B
$588K ﹤0.01%
26,000
TSM icon
1262
TSMC
TSM
$2.05T
$587K ﹤0.01%
2,100
-25,858
-92% -$6.32M
CABA icon
1263
CALL
Cabaletta Bio
CABA
$442M
$585K ﹤0.01%
+250,000
New +$429K
OCUL icon
1264
CALL
Ocular Therapeutix
OCUL
$1.84B
$585K ﹤0.01%
50,000
TTEK icon
1265
CALL
Tetra Tech
TTEK
$8.62B
$584K ﹤0.01%
17,500
SMMT icon
1266
Summit Therapeutics
SMMT
$10B
$584K ﹤0.01%
28,264
-238,991
-89% -$5.8M
CX icon
1267
Cemex
CX
$17.3B
$583K ﹤0.01%
+64,803
New +$553K
DRD
1268
DRDGold
DRD
$1.8B
$580K ﹤0.01%
+21,000
New +$376K
CC icon
1269
CALL
Chemours
CC
$2.57B
$575K ﹤0.01%
+36,300
New +$527K
KROS icon
1270
Keros Therapeutics
KROS
$198M
$571K ﹤0.01%
36,078
CYRX icon
1271
CryoPort
CYRX
$767M
$569K ﹤0.01%
60,004
BLND icon
1272
Blend Labs
BLND
$429M
$567K ﹤0.01%
+155,467
New +$558K
HIMS icon
1273
Hims & Hers Health
HIMS
$6.81B
$567K ﹤0.01%
+10,000
New +$512K
GEF icon
1274
Greif
GEF
$4.7B
$565K ﹤0.01%
+9,457
New +$611K
PRO
1275
DELISTED
PROS Holdings
PRO
$563K ﹤0.01%
+24,574
New +$400K

Similar funds

Caption Management's Q3 2025 Portfolio in Review

As of Q3 2025, Caption Management held 2,120 positions worth $12.8B, up 42% from $9.03B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Caption Management deployed $2.28B of net new capital in Q3 2025, opening 741 new positions and adding to 362 existing holdings. Its largest new stake was Amazon: 575,000 shares worth $126M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 3.1% of assets, up from 2.5% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Insmed, an estimated $25.8M trimmed.

  • Caption Management's largest Q3 2025 buy was Amazon: 575,000 shares worth $126M.
  • Caption Management added most to Sable Offshore Corp in Q3 2025, an estimated $34.9M increase.
  • Caption Management's biggest Q3 2025 reduction was Insmed, cutting an estimated $25.8M.
  • Caption Management fully exited Skechers in Q3 2025, selling an estimated $20.1M.
  • Caption Management's ten largest holdings make up 16% of its $12.8B portfolio in Q3 2025.
  • Caption Management opened 741 new positions and closed 513 in Q3 2025.
  • Caption Management's portfolio value rose 42% quarter-over-quarter to $12.8B.

Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.